en
Scientific article
Case report
English

Hypereosinophilia in patients with multiple sclerosis treated with natalizumab

Published inNeurology, vol. 77, no. 16, p. 1561-1564
Publication date2011
Abstract

To report asymptomatic hypereosinophilia as a potential side effect in patients treated with natalizumab, an α-4 integrin blocking agent.

Keywords
  • Adult
  • Antibodies, Monoclonal, Humanized/therapeutic use
  • Female
  • Humans
  • Hypereosinophilic Syndrome/complications/drug therapy
  • Middle Aged
  • Multiple Sclerosis/complications/drug therapy
Citation (ISO format)
ABBAS, Mohamed et al. Hypereosinophilia in patients with multiple sclerosis treated with natalizumab. In: Neurology, 2011, vol. 77, n° 16, p. 1561–1564. doi: 10.1212/WNL.0b013e318233b391
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
ISSN of the journal0028-3878
651views
0downloads

Technical informations

Creation12/12/2012 5:16:00 PM
First validation12/12/2012 5:16:00 PM
Update time03/14/2023 7:58:25 PM
Status update03/14/2023 7:58:25 PM
Last indexation01/16/2024 12:59:46 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack